Beike at the 2017 Shenzhen International Biotech Leadership Summit and International Biotech & Health Industry EXPO

Beike at the 2017 Shenzhen International Biotech Leadership Summit and International Biotech & Health Industry EXPO

Dr. Hu Xiang attended the opening ceremony of 2017 Shenzhen International Biotech Leadership Summit to discuss the opportunities and challenges of the development of biomedical big data The opening ceremony…

Beike Biotechnology Founder Sean Hu: Scientist CEO With a Universal Healthcare Dream

Beike Biotechnology Founder Sean Hu: Scientist CEO With a Universal Healthcare Dream

In a recent interview in the Beike Biotechnology headquarters in Shenzhen, Dr. Sean Hu shared his thoughts on the current situation of Beike and the field of cell therapy. He…

Beike Biotechnology’s Shenzhen Facility Earns AABB Accreditation

Beike Biotechnology’s Shenzhen Facility Earns AABB Accreditation

Shenzhen, China – Beike Biotechnology has been granted AABB accreditation for cord blood processing, storage, distribution, cell therapy activity (MSC, cord blood; MSC, placenta; NC, whole blood), somatic cell processing,…

Shenzhen Integrated Cell Bank is Preparing for AABB Accreditation

Shenzhen Integrated Cell Bank is Preparing for AABB Accreditation

In January of 2017 Beike Biotechnology held a meeting with local officials and the international accreditation center to prepare the Shenzhen Integrated Cell Bank for American Association of Blood Bank…

Karolinska Institute of Sweden Discuss Cooperation with Beike’s Shenzhen Cell Bank and Regional Cell Preparation Center

Karolinska Institute of Sweden Discuss Cooperation with Beike’s Shenzhen Cell Bank and Regional Cell Preparation Center

Oct 18, 2016 – A delegation from Sweden’s Karolinska Institute led by Professor Maria Masucci, vice president of international affairs, visited Beike Biotechnology’s headquarters and the International Stem Cell Base…

Specifications for Establishment and Management of Cellular Therapy Product Manufacturing Facility (SZDB/Z 188-2016)’ is Published Officially

Specifications for Establishment and Management of Cellular Therapy Product Manufacturing Facility (SZDB/Z 188-2016)’ is Published Officially

On Jun 22nd, Market Supervision Administration of Shenzhen Municipality had official approval of publication of ‘Specifications for Establishment and Management of Cellular Therapy Product Manufacturing Facility (SZDB/Z 188-2016)’ and formal…


1 2 8 9